share_log

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dukes Iain D.

SEC announcement ·  Mar 5 17:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more